Kairos Pharma, Ltd. (KAPA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 4.44M | 5.39M | 6.66M | 4.84M | 6.05M | 4.17M | 4.74M | 38K | 59K | 101K | 116K | 258K | 374K | 437K |
| Cash & Short-Term Investments | 3.67M | 4.49M | 5.58M | 3.03M | 3.62M | 1.27M | 3.22M | 21K | 40K | 93K | 99K | 232K | 357K | 437K |
| Cash Only | 3.67M | 4.49M | 5.58M | 3.03M | 3.62M | 1.27M | 3.22M | 21K | 40K | 93K | 99K | 232K | 357K | 437K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 1.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 768K | 896K | 1.08M | 1.8M | 55K | 38K | -1.51M | 0 | 0 | 8K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.3M | 1.15M | 1.41M | 1.83M | 1.89M | 2.05M | 262K | 992K | 913K | 864K | 832K | 720K | 631K | 599K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 22K | 62K | 102K | 142K | 182K | 222K | 262K | 302K | 342K | 382K | 422K | 462K | 502K | 542K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.28M | 1.09M | 1.31M | 1.69M | 1.71M | 1.38M | 0 | 690K | 571K | 482K | 410K | 258K | 129K | 57K |
| Total Assets | 5.74M | 6.54M | 8.07M | 6.67M | 7.94M | 6.22M | 5M | 1.03M | 972K | 965K | 948K | 978K | 1M | 1.04M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -27.63% | 5.21% | 61.19% | 547.86% | 716.56% | 544.15% | 427.85% | 5.32% | -3.28% | -6.85% | - | - | - | - |
| Total Current Liabilities | 431K | 199K | 402K | 676K | 805K | 992K | 1.67M | 3.01M | 2.72M | 2.4M | 2.21M | 1.94M | 1.74M | 1.63M |
| Accounts Payable | 0 | 0 | 0 | 676K | 805K | 0 | 1.53M | 2.9M | 2.71M | 2.4M | 2.21M | 1.93M | 1.73M | 1.63M |
| Days Payables Outstanding | - | - | - | - | - | - | 5.1K | 6.38K | 5.82K | 5.3K | 4.76K | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 142K | 106K | 4K | 0 | 4K | 4K | 4K | 4K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 431K | 199K | 402K | 0 | 0 | 992K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 10.31x | 27.07x | 16.56x | 7.16x | 7.52x | 4.20x | 2.84x | 0.01x | 0.02x | 0.04x | 0.05x | 0.13x | 0.22x | 0.27x |
| Quick Ratio | 10.31x | 27.07x | 16.56x | 7.16x | 7.52x | 4.20x | 2.84x | 0.01x | 0.02x | 0.04x | 0.05x | 0.13x | 0.22x | 0.27x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 448K | 0 | 677K | 657K | 638K | 612K | 602K | 592K | 582K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 677K | 657K | 638K | 612K | 602K | 592K | 582K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 448K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 431K | 199K | 402K | 676K | 805K | 1.44M | 1.67M | 3.68M | 3.37M | 3.04M | 2.82M | 2.54M | 2.33M | 2.21M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 142K | 783K | 661K | 638K | 616K | 606K | 596K | 586K |
| Net Debt | -3.67M | -4.49M | -5.58M | -3.03M | -3.62M | -1.27M | -3.08M | 762K | 621K | 545K | 517K | 374K | 239K | 149K |
| Debt / Equity | - | - | - | - | - | - | 0.04x | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -6.37x | -0.58x | -7.16x | -7.97x | -37.55x | -11.48x | -8.83x | -6.30x | - |
| Total Equity | 5.31M | 6.34M | 7.66M | 6M | 7.13M | 4.78M | 3.33M | -2.65M | -2.4M | -2.08M | -1.87M | -1.56M | -1.32M | -1.18M |
| Equity Growth % | -25.5% | 32.77% | 130.01% | 325.96% | 397.04% | 329.84% | 277.9% | -70.02% | -81.21% | -76.25% | - | - | - | - |
| Book Value per Share | 0.25 | 0.34 | 0.38 | 0.35 | 0.45 | 0.35 | 0.31 | -0.21 | -0.23 | -0.20 | -0.17 | -0.15 | -0.13 | -0.11 |
| Total Shareholders' Equity | 5.31M | 6.34M | 7.66M | 6M | 7.13M | 4.78M | 3.33M | -2.65M | -2.4M | -2.08M | -1.87M | -1.56M | -1.32M | -1.18M |
| Common Stock | 21K | 21K | 21K | 18K | 16K | 14K | 13K | 11K | 11K | 11K | 10K | 103K | 103K | 10K |
| Retained Earnings | -15.92M | -14.26M | -12.9M | -11.5M | -10.08M | -8.81M | -7.83M | -6.79M | -6.54M | -6.21M | -5.09M | -4.78M | -4.55M | -4.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 484K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |